PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • Recent FDA Approvals

    • Nurtec ODT (rimegepant sulfate), Biohaven Pharmaceuticals, Inc.
    • Oriahnn (elagolix/estradiol/norethisterone), AbbVie Inc.

    Labeling Updates

    • K e y
    • BlackBox_opt Boxed Warning
    • Triangle_opt Other Warnings*
      *Warnings and Precautions; Adverse Reactions; Drug Interactions; and Contraindications
    • Circle_opt Updates to Indications/Dosage
    • Diamond_opt Other Updates
      Other labeling changes; added to PDR database
    Triangle_opt
    Diamond_opt
    Creon (pancrelipase)
    BlackBox_opt
    Triangle_opt
    Circle_opt
    Diamond_opt
    Depakote ER (divalproex sodium)
    BlackBox_opt
    Triangle_opt
    Circle_opt
    Diamond_opt
    Depakote Sprinkle Capsules (divalproex sodium)
    BlackBox_opt
    Triangle_opt
    Circle_opt
    Diamond_opt
    Depakote Tablets (divalproex sodium)
    Triangle_opt
    Diamond_opt
    Duopa (carbidopa/levodopa)
    Diamond_opt
    Kaletra (lopinavir/ritonavir)
    Triangle_opt
    Circle_opt
    Diamond_opt
    Diamond_opt
    Mavyret (glecaprevir/pibrentasvir)
    Circle_opt
    Diamond_opt
    Nimbex (cisatracurium besylate)
    Nurtec ODT (rimegepant sulfate) - RECENT FDA APPROVAL
    Oriahnn (elagolix/estradiol/norethisterone) - RECENT FDA APPROVAL
    Diamond_opt
    Rinvoq (upadacitinib)
    Triangle_opt
    Diamond_opt
    Skyrizi (risankizumab-rzaa)
    Triangle_opt
    Diamond_opt
    Synthroid (levothyroxine sodium)
    Triangle_opt
    Trokendi XR (topiramate)
    Triangle_opt
    Diamond_opt
    Venclexta (venetoclax)
  •  

    To have full prescribing information faxed or mailed to you, call 1-800-261-2313.

    The FDA encourages healthcare professionals to recognize and report misleading prescription drug advertising. To report: call 855-RX-BADAD (855-792-2323) or email BadAd@fda.gov. For more information, visit www.fda.gov.
    Report adverse events to MedWatch.